The first aim of our study was to examine the association between common variants in VDR [rs2228570 (FokI), rs1544410 (BsmI), rs7975232 (ApaI), rs731236 (TaqI) and rs11568820 (Cdx2)] and lung cancer risk in the Polish population. Genotyping and statistical analysis which included Chi-square test with Yates correction and haplotype frequency analysis were performed on a series of 840 consecutively collected lung cancer patients and 920 healthy controls. The second aim was to evaluate the link between serum 25(OH)D concentration and the number of lung cancers in a subgroup of 200 patients. A separate control group that consisted of 400 matched (by age, sex, smoking habits and the season of blood collection) healthy individuals was used to avoid posterior adjustment on the matched variables. Statistical analysis with the use of Chi-square test with Yates was performed. We found no statistically significant difference in the distribution of the allels of studied VDR variants among cases and controls. A statistically significant over-representation of VDR haplotypes: rs731236_A 1 rs1544410_T [odds ratio (OR) 5 2.43, 95% confidence interval (CI) 5 1.11-5.32, p < 0.001], rs731236_G 1 rs1544410_T (OR 5 1.54, 95% CI 5 1.31-1.81, p < 0.001) and rs731236_G 1 rs1544410_C (OR 5 0.04, 95% CI 5 0.03-0.07, p < 0.001) was detected. We found a tendency toward an increased number of lung cancers among individuals with low serum levels of 25(OH)D. To answer the question, whether VDR can be regarded as lung cancer susceptibility gene and low 25(OH)D serum levels is associated with lung cancer occurrences, additional, multicenter study needs to be performed.
Lung cancer is the leading cause of cancer death in the world. 1 Despite recent advances in diagnosis and treatment of disease, prognosis remains poor. In 2013 lung cancer was one of the most commonly diagnosed cancers among men (14,609 new cases) and second-after breast cancer-among women (6,915 new cases) in Poland. 2 In 2013 a total of 15,981 men and 6,647 women died of lung cancer in Poland. Vitamin D has several important functions that are involved in the activation of a number of molecular pathways that mediate a multitude of functions. The active form of vitamin D-1,25-(OH) 2 D 3 -acts via the steroid hormone receptor VDR and regulates expression of >900 genes involved in a wide variety of physiological processes. 3, 4 In vitro and in vivo studies demonstrate that vitamin D is involved in regulation of cellular migration, proliferation, extracellular matrix (ECM) degeneration and other processes related to protecting against tumorigenesis, such as, protection cell against DNA damage, cell cycle arrest, apoptosis, angiogenesis and interaction with the immune system. 5 Vitamin D deficiency has been described as a potent factor associated with the development and progression of numerous diseases including autoimmune, cardiovascular, respiratory, reproductive and endocrine malfunctions as well as several types of malignancy, including prostate, colorectal, breast cancers and melanoma. 6 A number of potential single nucleotide functional variants have been identified in VDR. Recent studies support the notion that genetic variants of VDR are associated with cancers risk, including lung cancer. [7] [8] [9] However, until now only Asian (China), Turkish and North African (Tunisia) populations have been studied. To evaluate the association between serum vitamin D levels with lung cancer occurrence we analyzed serum 25(OH)D concentration and VDR genotype among 200 consecutive lung cancer patients and 400 matched healthy controls. To check for an association between VDR common variants and lung cancer risk, we genotyped 840 consecutive patients with lung cancer and 920 healthy individuals and evaluated the likelihood of there being an effect.
Material and Methods

Lung cancer patients
The case group consisted of 840 consecutively collected patients with lung cancer diagnosed between January 2008 and December 2015 (214 women, 626 men; mean age: 61 years; range: 28-88 years of age). Serum was collected in a subgroup of 200 patients with lung cancer diagnosed between January 2013 and December 2015 (78 women, 122 men; mean age: 66 years; range: 39-83 years of age). All patients were diagnosed at the Clinical Thoracic Surgery Department of the Pomeranian Medical University in Szczecin.
Patients with any malignancy diagnosed in the past were excluded from the study. Blood samples from all cases and 200 serum samples were taken prior to treatment, at the time of cancer diagnosis. All 200 participants were fasting at the time of the serum collection and declared that they were not taking vitamin D supplements. Overall, the patient participation rate exceeded 75%.
Controls
Two control groups were established. The first group consisted of 920 healthy individuals with a negative cancer family history (230 women, 690 men; age range: 28-88 years of age), who were matched to the 840 lung cancer cases with respect to year of birth (62 years), gender, smoking habit) ( Table 1 ). The second group consisted of additional 400 healthy individuals who were matched to the 200 cases (two healthy controls for each case) with respect to year of birth (63 years), gender, smoking habit, season of blood collection and total number of cancers among first degree relatives ( Table 2) . We used matched control-cases to avoid posterior adjustment the matched variables.
Members of the control groups were part of a populationbased study of 1.7 million inhabitants of West Pomerania designed to identify familial aggregations of cancer which was undertaken within the Department of Genetics and Pathomorphology, Szczecin.
The study conformed to the Declaration of Helsinki, and all participants signed an informed consent document prior to participation. The study was approved by the institutional review board of the Pomeranian Medical University.
Methods
Measurement of 25(OH)D level in serum
Serums were separated from 4 mL of venous blood by centrifugation (11,850g, 10 min) and stored at 2808C for further analysis. Before analysis the serum samples were slowly defrosted at room temperature. After complete defrosting, 250 lL of serum was added to an eppendorf tube containing 500 lL cold ethanol. After 10 min of shaking the sample was centrifuged (6,800g, 15 min). After that, the supernatant was transferred in to a prepared SPE column containing octadecyl (C18). SPE columns were placed on an extracting system. The procedure for the preparation of the SPE columns and extraction of 25(OH)D consisted of following steps: i) wash each column by methanol (2 mL); ii) wash with a 1:3 ethanol-water mix (3 mL); iii) add the prepared supernatant; iv) wash with water (3 mL); v) wash with a 2:3 methanol-water mix (3 mL) and vi) elution of 25(OH)D by methanol (500 lL) in to a glass vial and use immediately for chromatography analysis.
Quantitative analysis of 25(OH)D was performed on HPLC Flexar Systems (Perkin Elmer) which consisted of a: binary gradient pump, autosampler, thermostatic column chamber and UV-vis detector. Chromatographic analysis was conducted on LiChrospher RP-18 (Macherey-Nagel) column.
The concentration of vitamin D3 was calculated based on sample peak area and two calibration curves. Calibration curves were determined before and after the measurement series of samples. Coefficient of determination (R 2 ) of linear regression was maintained at least at 0.95. The relative standard deviation (RSD) for our measurements was 1.55%.
Molecular analysis
Five common variants in VDR were genotyped: rs2228570 (FokI), rs1544410 (BsmI), rs7975232 (ApaI), rs731236 (TaqI) and rs11568820 (Cdx2). DNA samples were obtained from peripheral blood of individuals, as previously described. 10 Molecular analysis was performed using real-time PCR with TaqMan probes. Reactions were performed according to the manufacturer's instructions. Randomly selected samples were sequenced by the Sanger sequencing method. Sequencing was performed with universal primers using the ABI PRISM Big Dye Terminator Cycle (Applied Biosystems, Foster City, CA).
What's new?
This is the first case-control study to evaluate the associations between serum 25(OH)D levels, five common variants in VDR gene and lung cancer incidence in the Slavic (Polish) population. Authors found significant association between rs731236-rs1544410 haplotype and increased risk of lung cancer. A tendency toward an increased number of lung cancers among individuals with low serum levels of 25(OH)D was observed.
Statistical analysis
Genotype variants. To determine whether five VDR gene single nucleotide polymorphisms (SNPs: rs2228570, rs1544410, rs7975232, rs731236 and rs11568820) are associated with lung cancer risk in the Polish population, v 2 test
with Yates correction was used. The VDR allele frequencies of the case population were compared to the matched cohort of healthy controls.
Haplotype frequencies analysis. The relative haplotype frequencies were estimated using the genetic statistical software package "haplo.stats" for R (http://cran.rproject.org/src/contrib/Descriptions/haplo.stats.html).
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The haplotype frequencies are estimated with the help of generalized linear models (GLMs) separately for cases and controls and them compared. The use of GLMs instead of the more extended expectation-maximization (EM) algorithm has the advantage of providing efficient score statistics both for global tests and haplotype-specific tests.
Vitamin D serum concentration. To evaluate the association between vitamin D with the number of lung cancers, we measured circulating 25(OH)D levels in the 200 lung cancer patients and 400 controls divided into:
1. two groups of 25(OH)D concentration: those with 20 ng/ mL (defined as deficiency according to WHO guidelines) and >20 ng/mL (defined as suboptimal to optimal concentration) and 2. quartiles.
Compartments with the highest concentration of 25(OH)D were considered as the "reference" value for the calculation of odds ratios (ORs).
A comparison of the mean 25(OH)D serum concentration in cases versus controls was undertaken using the students t test.
To investigate the correlation between circulating 25(OH)D levels and the five common VDR variants, v 2 test
with Yates correction was used. Bonferroni correction for multiple testing was applied to all results that demonstrated a significant difference between the cases and controls.
Results
Genotype analysis
There were no significant differences in the frequencies of five genotypes of VDR (rs2228570 (FokI), rs1544410 (BsmI), rs7975232 (ApaI), rs731236 (TaqI), rs11568820 (Cdx2)) between cases and controls ( Table 3) . Two of the variants, rs731236 (TaqI) and rs1544410 (BsmI) are in linkage disequilibrium (previously described by Gapska et al. 12 in the Polish population).
Haplotype frequency
In the haplotype frequency analysis we found significant associations for rs731236_A 1 rs1544410_T haplotype [OR 5 2.43, 95% confidence interval (CI) 5 1.11-5.32, p < 0.001] and for rs731236_G 1 rs1544410_T haplotype (OR 5 1.54, 95% CI 5 1.31-1.81, p < 0.001) with an increased risk of lung cancer. Haplotype rs731236_G 1 rs1544410_C occurred less frequently in the lung cancer patients than in the control group, suggesting this haplotype is associated with a reduced risk of lung cancer (OR 5 0.04, 95% CI 5 0.03-0.07, p <0.001) ( Table 4) . Due to the small number of carriers of certain haplotypes, we excluded Cdx2 from our haplotype analysis, as it was also impossible to estimate the prevalence of the following haplotypes: A-T-A-A (rs731236-rs1544410-rs2228570-rs7975232) and A-T-A-C, A-T-G-A and A-T-G-C. Cancer Genetics and Epigenetics
25(OH)D levels
We found no statistically significant difference in the mean serum 25(OH)D concentration between cases and controls-17.1 ng/mL versus 17.2 ng/mL, p 5 0.82.
Analysis of the defined clinical 25(OH)D concentration ranges 20 ng/mL and >20 ng/mL revealed a nonsignificant tendency toward an increased incidence of lung cancer occurrence among individuals with low levels of 25(OH)D (Table 5) .
Consistently, the analysis of quartiles also revealed a linear trend toward an increased incidence of lung cancers among individuals with low 25(OH)D levels, with declining 25(OH)D concentration we observed an increase in the value of OR. The greatest number of cancers was found in the lowest quartile of serum 25(OH)D concentration (OR 5 1.61, p 5 0.07) ( Table 6 ).
Analysis of the correlation between serum 25(OH)D concentration and VDR genotypes
Combined analysis of serum 25(OH)D concentration, VDR variants and lung cancer occurrence revealed no statistically significant findings (data not shown).
Discussion
Herein we present the first report detailing the prevalence of five common VDR variants and serum 25(OH)D concentration among Slavic (Polish) lung cancer patients compared to control population.
Our results point at a moderate association of VDR and lung cancer risk. None of the single genotypes including rs11568820 (Cdx2) studied for the first time herein, were significantly over-represented among lung cancer patients neither in the heterozygotenor homozygote state. However, we found an association between the rs731236_A 1 rs1544410_T haplotype (OR 5 2.43, p < 0.001, after Bonferroni correction) and rs731236_G 1 rs1544410_T haplotype (OR 5 1.54, 
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p < 0.001, after Bonferroni correction) and an increased risk of lung cancer. Haplotype rs731236_G 1 rs1544410_C occurred less frequently in the case group suggesting its associated with a reduced risk of lung cancer (OR 5 0.04, p < 0.001, after Bonferroni correction).
In a recently report of 240 lung cancer patients and 280 healthy individuals from the North African population, Kaabachi et al. showed a significantly increased risk of lung cancer among carriers of the rs2228570 (FokI) variant. There was no significant association with lung cancer risk of the rs1544410 (BsmI) and rs731236 (TaqI) 13 polymorphisms. Two recently published meta-analyses of five studies involving 602 patients with lung cancer and 662 healthy controls revealed no association between the ApaI variant and risk of lung cancer and an increased risk of lung cancer among carriers of rs1544410 (BsmI) bb (GG) or rs731236 (TaqI) TT (TT) genotypes. 14, 15 The differences of our results with that reported in the literature data may be the result of population stratification-so far only the Asian and Turkish population have been examined.
To date, only one study has presented results of the VDR haplotype frequency and lung cancer risk. Kaabachi et al. reported that haplotypes: i) G-A-C (rs1544410-rs7975232-rs731236) were significantly associated with increased risk of lung cancer (OR 5 4.48, p 5 0.0128). ii) A-C-T (rs1544410-rs7975232-rs731236) (OR 5 5.82, p 5 0.008). 13 Our results are consistent with the possible association of rs1544410-rs731236 (BsmI-TaqI) haplotype and lung cancer risk. Further investigation on a larger group of patients is needed to confirm this association with lung cancer risk.
The results from a recent meta-analyses suggests a possible protective role of 25(OH)D in lung cancer development. Chen et al. in their meta-analysis of ten lung cancer studies, that involved 2,227 patients from the USA, Finland, Norway, Germany, Denmark and Australia and 120,402 healthy controls, revealed a significant (RR 0.95, 95% CI 0.91-0.99, p 5 0.017) reduction in lung cancer risk for each 10 nmol/L increase in 25(OH)D. 16 Zhang et al. 17 in a meta-analysis of 12 studies, involving 5,408 patients with lung cancer and 283,370 healthy controls, obtained similar results pointing to an inverse association between high serum vitamin D concentration and lung cancer risk (RR 0.83; 95% CI: 0.77-0.90; p < 0.001).
In our study, we found a tendency toward an increased number of lung cancers among individuals with low serum levels of 25(OH)D. Although statistically nonsignificant, our finding is consistent with that published to date. The greatest number of cancers were found among individuals with 25(OH)D concentration in the lowest quartile (Q1: OR 1.61; p 5 0.07) as well as in the subgroup of patients with levels of 25(OH)D that are defined as being deficient (20 ng/mL: OR 1.40; p 5 0.09).
To determine whether low serum concentration of 25(OH)D is a risk factor for lung cancer or is the result of cancer development, serum should be collected at least 2 years before cancer diagnosis-something that is unlikely to occur unless a population wide study of vitamin D is undertaken.
A short coming of our study is the number of cases and controls used for the evaluation of 25(OH)D and its relationship to lung cancer risk. The evaluation of additional cases and controls would provide more statistical power to reveal a significant result. Approximately 70% of the Polish population have a vitamin D deficiency 18 -the real value may be much higher. Our results and data reported by others indicate the need for further studies to determine the effect of vitamin D supplementation on the risk of lung cancer and the survival of patients with disease.
Conclusions
Our study has identified an association between VDR polymorphisms with lung cancer risk in the Polish population and points toward the possible association between low 25(OH)D serum concentration and an increased likelihood of disease. To answer the question, whether VDR can be regarded as lung cancer susceptibility gene, additional, large multicenter association studies need to be performed. Further work is required to evaluate the relationship between vitamin D and calcium intake in relation to lung cancer risk. 
